Nxera Pharma to Present at the 44th Annual J.P. Morgan Healthcare Conference
Globenewswire·2026-01-05 13:58

Company Overview - Nxera Pharma is a technology-powered biopharma company focused on developing specialty medicines to address unmet medical needs in Japan and globally [2][4] - The company has established a new-generation commercial business in Japan, targeting a large and growing market for innovative medicines [3] Pipeline and Development - Nxera Pharma is advancing an extensive pipeline of over 30 active programs, utilizing its unique NxWave™ discovery platform, from discovery to late clinical stages [4] - The pipeline includes potentially first- and best-in-class candidates aimed at addressing major unmet needs in rapidly growing medical areas such as obesity, metabolic disorders, neurology/neuropsychiatry, and immunology/inflammation [4] Workforce and Locations - The company employs approximately 400 talented individuals across key locations including Tokyo, Osaka, London, Cambridge, Basel, and Seoul [5]

Nxera Pharma to Present at the 44th Annual J.P. Morgan Healthcare Conference - Reportify